跳至主要内容
临床试验/ISRCTN27860457
ISRCTN27860457已完成未知

ON-EPIC Oral nitrate supplementation to enhance pulmonary rehabilitation in chronic obstructive pulmonary disease: a multi-centre, double blind, placebo-controlled, cross-over study

Imperial College, London (UK)0 个研究点目标入组 165 人开始时间: 2014年10月29日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
165

研究概览

简要总结

2020 results in https://pubmed.ncbi.nlm.nih.gov/32376732/ (added 19/11/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Patients will need to have a clinical and spirometric diagnosis of COPD, GOLD stage II-IV and with an MRC score of 3-5 or to be functionally limited

排除标准

  • 1. Clinically unstable patients (within one month of exacerbation)
  • 2. Within one month of completing pulmonary rehabilitation
  • 3. Significant comorbidity limiting exercise tolerance
  • 4. Significant renal impairment (estimated glomerular filtration rate (eGFR) <50 ml.min-1)
  • 5. Hypotension (systolic blood pressure <100 mmHg)
  • 6. Pregnancy
  • 7. Use of nitrate based medication
  • 8. Other reason for benefit from nitrate supplementation (ischaemic heart disease, peripheral arterial disease)
  • 9. Use of long-term oxygen therapy

研究者

发起方
Imperial College, London (UK)

相似试验